Genomics Biotech

Shanghai and Hong Kong launch a cross-border AI and biotech bootcamp that pairs Hong Kong R&D with Shanghai commercialization to speed health AI innovations to market.

SUIC and VisionRenu sign an MOU to advance AI-driven biotech and precision medicine, applying DBTL, gene editing, and ophthalmic and brain-health tech for global markets.

ChemT Biotechnology raised $4M to scale CelMo, an AI virtual cell that models CHO, T cells and more to speed, lower cost and raise yields in biologics production.

Puma Biotechnology director Troy Wilson sold 77,748 shares under a 10b5-1 plan amid recent RSU vesting. We break down the trade, Q1 2026 miss, and valuation view.

The Netherlands has expanded the Vifo Act to include AI and biotechnology. Read what this means for M&A, VC and PE investing in Dutch tech firms.

How AI is reshaping drug discovery and programmable therapeutics, why investors poured billions, and what scientific and data bottlenecks remain.

Sino Biological’s XpressMax cell-free kit accelerates AI-driven antibody screening by enabling rapid protein synthesis, high-throughput assays and tighter experimental loops.

Tolemy Bio raised €1.4M led by Norrsken Evolve to launch Orbit, an AI-native platform that turns lab experiments into reusable intelligence for mid-sized biopharma.

Authoritative overview of how AI is transforming biotechnology: drug discovery, precision diagnostics, bioprocess optimization, clinical trials and market outlook.